Main Session
Sep 27
SS 02 - Escalate, De-escalate, or Substitute? Trials Shaping Prostate Cancer Care

109 - <em>I</em>ntermittent Androgen Deprivation Therapy with or without <em>St</em>ereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive <em>O</em>ligometastatic <em>P</em>rostate Cancer: A Randomized Study (i-STOP)

03:40pm - 03:50pm ET

Presenter(s)

Rachel Glicksman, MD - University of Toronto, Toronto, ON